2025 International Congress » Pediatric Movement Disorders

Antisense Oligonucleotide Treatment in Ataxia-Telangiectasia

C. de Gusmao, C. Achkar, B. Ahtam, C. Berde, L. Bush, D. Chin, B. Darras, K. Faour, D. Friedmann, B. Gagoski, B. Goodlett, E. Grant, A. Gupta, S. Hills, A. Hu, J. Kim, A. Kuniholm, C. Lentucci, J. Lopes, E. Lopez, A. Luddy, B. Margus, M. Meserve, V. Natale, T. Nakayama, A. O’Connor, C. Rabideau, O. Riccardi, R. Schule, E. Sherril, L. Solo, A. Soucy, V. Suslovitch, M. Synofzik, J. Thornton, T. Yu (Boston, USA)

Bulbar Symptoms Precede Diagnosis in Early-Onset, but not in Typical- to Late-Onset Friedreich Ataxia: Real-World Data From Medical Claims

S. Kuo, S. Nayar, B. Bian, D. Gomes, S. England, J. Mckay, T. Wang, R. Avila, S. Perlman (New York, USA)

Characterizing the Patient Clinical Journey Before and After Diagnosis of Friedreich Ataxia and Differences by Age at Diagnosis

A. Henriquez, M. Hatcher, B. Bian, A. Didonato, S. England, Q. Ip, X. Ma, J. Mckay, R. Avila (Seattle, USA)

Clinical and Genetic spectrum of Developmental dyskinetic encephalopathy – Experience from a Tertiary care centre

A. Vijayaraghavan, S. Nair, S. Sundaram (Thiruvananthapuram, India)

Clinical Characteristics and Antipsychotic Medication Use in Pediatric Population Diagnosed With Tourette Syndrome

K. Tomczak, J. Swindle, F. Dabbous, G. Karkanias, S. Atkinson, F. Munschauer, F. Mazhar, C. Pettersson, S. Wanaski, T. Cunniff, D. Isaacs (Boston, USA)

Design and Outcome Measures of BRAVE, a Phase 3 Study of Omaveloxolone in Pediatric Patients With Friedreich Ataxia

D. Lynch, M. Delatycki, M. França, A. Durr, E. Bertini, S. Perlman, A. Arizpe, R. Domingo-Horne, S. Fradette, S. Sinks, M. Murai, N. Folschweiller (Philadelphia, USA)

Determination of the Minimal Clinically Important Difference in the Yale Global Tic Severity Scale Total Tic Score in a Pediatric Population With Tourette Syndrome Receiving Pharmacotherapy

J. Mcguire, G. Karkanias, R. Bittman, S. Atkinson, F. Munschauer, S. Wanaski, T. Cunniff, D. Gilbert (Baltimore, USA)

Developing an Electronic Medical Record-Based Dystonia Tracking Tool for use in a Pediatric Hospital Setting

L. Vogt, N. Al Azri, A. Leblanc-Millar, M. Eckstein, E. Patterson, S. Silver, C. Gorodetsky (Toronto, Canada)

Efficacy and Safety of Ecopipam for Tourette Syndrome (TS): Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal Trial

K. Tomczak, S. Atkinson, D. Kim, M. Miller, P. Rice, G. Karkanias, F. Munschauer, S. Wanaski, T. Cunniff, D. Gilbert (Chicago, USA)

Expanding the Clinical Spectrum of Fejerman Syndrome: Insights from Video EEG and Long-Term Follow-Up

M. Hull, M. Sudheendra, M. Gonzalez, B. Evans, D. Takacs, A. Katyayan (Houston, USA)

Expanding the Phenotypic Spectrum of CACNA1A Variants: A Single-Center Experience

H. Alfaris, S. Yoganathan, P. Jain, M. Moharir, G. Costain, V. Chau, C. Gorodetsky (Toronto, Canada)

Exploring the Role of Aperiodic and Periodic Spectral Activity in Guiding Deep Brain Stimulation Electrode Selection for Childhood Dystonia

T. Larsh, S. Vadivelu, J. Skoch, T. Lipps, D. Gilbert, S. Wu (Cincinnati, USA)

Genetic and clinical spectrum of pediatric hyperkinetic movement disorders in a Spanish tertiary center

JD. Ortigoza Escobar, B. Antomil Guerrero, L. Marti-Sanchez, D. Yubero, C. Xiol Viñas, A. Alcalá Sanmartín, C. Hernando Davalillo, J. Armstrong, L. Martorell (Barcelona, Spain)

GNAI1-Associated Childhood-Onset Hyperkinetic Movement Disorder: A Case Report

T. Larsh, A. Espay, D. Gilbert, S. Wu (Cincinnati, USA)

Increased Health Care Utilization in Children/Adolescents With Tourette Syndrome Treated With Dopamine D2 Receptor Antagonists: An Electronic Medical Records Database Analysis

D. Isaacs, J. Swindle, F. Dabbous, G. Karkanias, S. Atkinson, F. Munschauer, F. Mazhar, C. Pettersson, S. Wanaski, T. Cunniff, K. Tomczak (Nashville, USA)

Management of Grisel’s Syndrome with Botulinum Toxin: A Case Report

L. Kenjaeva, A. Azimov, G. Kendjaeva (Tashkent, Uzbekistan)

Preliminary Results From an Italian Multicentric Study on Inherited Synaptopathies Characterized by Movement Disorders and Epilepsy

L. Pollini, S. Galosi, F. Nardecchia, M. Mastrangelo, M. Bologna (Rome, Italy)

Real-World Adverse Event Profile in Children and Adolescents With Tourette Syndrome Treated With Dopamine D2 Receptor Antagonists (D2RAs) Compared With Non-D2RAs

K. Tomczak, J. Swindle, F. Dabbous, G. Karkanias, S. Atkinson, F. Munschauer, F. Mazhar, C. Pettersson, S. Wanaski, T. Cunniff, D. Isaacs (Bethesda, USA)

Spectrum and Evolution of Movement Disorder Phenomenology in a Pediatric Powassan Encephalitis Case Series

R. Lindsay, K. Yang, V. Quiroz, R. Srouji, D. Ebrahimi-Fakhari (Calgary, Canada)

Stroke, Chronic Ataxia and Tremor in a Pediatric Patient with c.2137C>A Genetic Variant in CACNA1A

A. Vargas Nino, H. Alfaris, C. Gorodetsky (Toronto, Canada)

The Efficacy of Neuromodulation for Motor Recovery in Children with Hemiparesis Due to Perinatal Stroke: A Systematic Review and Meta-Analysis.

I. Andrade, A. de Almeida (Vitória da Conquista, Brazil)

The Impact of Friedreich Ataxia Progression on Mobility

S. Kuo, S. Farooq, C. Harrod, J. Smith, M. Urbich, P. Pemberton-Ross, R. Lawson (New York, USA)

The Phenotypic Spectrum of ATP1A3-Related Disorders: A Brazilian Cohort

V. Procaci, A. Gomes, R. Hora, P. Lima, J. Ferrer, D. Maia, F. Cardoso, H. Linden, M. Krueger, E. Leão, T. Tonholo Silva, P. Nóbrega, O. Barsottini, J. Pedroso (São Paulo, Brazil)

Treatment of Status Dystonicus with Deep Brain Stimulation in a Child with SOX2-Anophthalmia Syndrome

A. Morris, A. Viehoever (Saint Louis, USA)

Understanding Referral Patterns to a Pediatric Movement Disorders Clinic: A Quality Improvement Project

A. Leblanc-Millar, C. Gorodetsky (Toronto, Canada)